Learn More
R&D Systems™ Human IL-19 Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 1035IL025
Description
The Recombinant Human IL-19 Protein is derived from E. coli. The Recombinant Human IL-19 Protein has been validated for the following applications: Bioactivity.Specifications
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. | |
18 kDa (monomer) | |
25μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Recombinant | |
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
29949 | |
IL-19 | |
E. coli-derived human IL-19 protein Leu25-Ala177,with an N-terminal Met | |
Unconjugated | |
Reconstitute at 100μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.